Clinical Trial Update: Circulating Tumor DNA Based Adjuvant Chemotherapy in Stage II Colon Cancer Patients: the MEDOCC-CrEATE Trial [NA]

View source ↗

Summary

The MEDOCC-CrEATE trial investigates using circulating tumor DNA to guide adjuvant chemotherapy in patients with stage II colon cancer. Recruitment for the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Snippet

Sponsor: UMC Utrecht | Conditions: Circulating Tumor DNA, Recurrence | NA | Status: RECRUITING